TOPICS

• 椷榓俇擭搙 擔杮堛椕尋媶奐敪婡峔(AMED) 嫶搉偟尋媶僾儘僌儔儉 僔乕僘俠偵嵦戰偝傟傑偟偨丅
  壽戣柤乽旛拁丒嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺堛巘庡摫帯尡乿(戙昞: 徏杮 夒懃丒寣塼撪壢嫵庼)
• Blood Advances帍偵丄恖岺愒寣媴(僿儌僌儘價儞 儀僔僋儖)偺戞堦憡帋尡偺寢壥偑曬崘偝傟傑偟偨乮埉愳堛戝丒杒戝昦堾傎偐偲偺嫟摨乯丅
  僞僀僩儖: First-in-human phase 1 trial of artificial red blood cells, hemoglobin vesicles, developed as a transfusion alternative
  DOI:/10.1182/bloodadvances.2022007977
  
• 戞17夞 崙嵺寣塼戙懼暔妛夛 傪惉岟棤偵廔偊傑偟偨丅嶲壛幰偺奆條丄偛巟墖偔偩偝偄傑偟偨奆條偵怱傛傝屼楃怽偟忋偘傑偡丅
  (XVII-International Symposium on Blood Substitutes and Oxygen Therapeutics)
  夛婜丗2019擭11寧21-23擔丄夛応丗撧椙弔擔栰崙嵺僼僅乕儔儉酧
  
  
  
  

---

NEWS怴拝忣曬

2025擭1寧6擔

Artificial Organs帍偵丄恖岺愒寣媴惢嵻傪梡偄傞慼惗偵傛傞怱嬝曐岇岠壥偵偮偄偰2025擭弶姧偵宖嵹偝傟傑偟偨(杊塹堛戝偲偺嫟摨)丅傑偨丄Cover Image偲偟偰徯夘偝傟傑偟偨丅
Liposome-encapsulated hemoglobin rescues hemorrhagic shock heart through anti-ischemic and anti-arrhythmogenic effects on myocardium in repetitive 65% bleeding rat model.
DOI:10.1111/aor.14858
Cover image DOI:10.1111/aor.14777

2024擭12寧5-6擔

戞31夞擔杮寣塼戙懼暔妛夛擭師戝夛乮摨巙幮戝妛乯偵偰丄尋媶敪昞傪偟傑偟偨丅
1) 旛拁丒嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺幚梡壔傪栚巜偡尋媶 (庰堜)
2) 巁慺暘埑偵墳摎偟偰儗僆儘僕乕偑曄壔偡傞僿儌僌儘價儞-PEG僎儖偺奐敪 (徏暯)

2024擭11寧14-18擔

戞19夞 崙嵺寣塼戙懼暔妛夛 (19th-ISBS-2024, Maryland) 偵偰丄尋媶敪昞傪偟傑偟偨丅
1) The journey here and the road ahead with ISBS (Opening Session) (庰堜)
2) Encapsulated HBOCs (Benefits and Risks) (庰堜)
3) Bio-Synthetic Blood Components in Active Human Trials, HbV (庰堜)
4) A synthetic strategy for hemoglobin-PEG architectures using supramolecular polymerization (徏暯)
5) Hemoglobin vesicles improve neurological outcome after cardiac arrest in rats (掃揷)

2024擭11寧7擔

Resuscitation Plus帍偵丄怱掆巭儌僨儖摦暔偵懳偟HbV搳梌偱慼惗偡傞偙偲偵傛傝擼恄宱妛揑梊屻偑夵慞偡傞寢壥偑宖嵹偝傟傑偟偨丅
Hemoglobin vesicles improve neurological outcomes after cardiac arrest in rats.
DOI:10.1016/j.resplu.2024.100819

2024擭10寧5擔

戞74夞丂擔杮栻妛夛娭惣巟晹憤夛丒戝夛 偵偰丄嶳揷偑尋媶敪昞傪偟傑偟偨丅
墘戣丗暋崌峈巁壔嵻偺峈巁壔擻偲嶌梡婡彉丂乗憡忔岠壥偲儕億僜乕儉壔岠壥偵偮偄偰乗

2024擭9寧25-27擔

戞73夞 崅暘巕摙榑夛乮怴妰乯偵偰丄徏暯偑尋媶敪昞傪偟傑偟偨丅
墘戣丗僿儌僌儘價儞偺僒僽儐僯僢僩娫憡屳嶌梡偺曄壔傪棙梡偟偨暋悢巋寖墳摎惈僴僀僪儘僎儖

2024擭8寧19擔

椷榓6擭搙 擔杮堛椕尋媶奐敪婡峔(AMED) 嫶搉偟尋媶僾儘僌儔儉 僔乕僘俠乽旛拁丒嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺堛巘庡摫帯尡乿偺戞1夞斍夛媍傪丄WEB奐嵜偟傑偟偨丅

2024擭8寧17擔

Redox Biology帍偵丄堦巁壔扽慺傪寢崌偟偨愒寣媴偺旕傾儖僐乕儖惈帀朾娞墛偵懳偡傞岠壥偵偮偄偰宖嵹偝傟傑偟偨(孎戝栻傎偐偲偺嫟摨)丅
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation.
DOI:10.1016/j.redox.2024.103314

2024擭8寧3擔

戞10夞 撧椙導桝寣丒憿寣帯椕尋媶夛偵偰敪昞偟傑偟偨丅
嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺幚梡壔傪栚巜偡尋媶

2024擭8寧1擔

JST僒僀僄儞僗億乕僞儖偱徯夘偝傟傑偟偨丅
乽恖岺愒寣媴惢嵻偱棧搰傗傊偒抧傕媬偊 撧椙導棫堛戝昦堾偑帯尡傪杮奿壔傊乿

2024擭7寧26擔

戞25夞 嵶朎堏怉丒堚揱巕帯椕WEB僙儈僫乕偵偰敪昞偟傑偟偨丅
嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺幚梡壔傪栚巜偡尋媶

2024擭7寧10擔

戞40夞 擔杮DDS妛夛妛弍廤夛 偵偰敪昞偟傑偟偨丅
恖岺愒寣媴(僿儌僌儘價儞 儀僔僋儖)傪陽帟椶偵搳梌偟偨屻偺傾僫僼傿儔僉僔乕斀墳偺桳柍偺専徹

2024擭7寧9擔

TBS乽傂傞偍傃乿
亀恖岺愒寣媴亁側偤巼怓丠寣塼宆栤傢偢桝寣偱偒5擭曐懚傕乧奐敪幰偑夝愢

2024擭7寧2擔

MBS枅擔曻憲
乽乽偳傫側姵幰偝傫偱傕丄寣塼宆傕娭學側偔擖傟傜傟傞乿俙丒俛丒俷丒俙俛宆傪栤傢側偄亀恖岺寣塼亁偺奐敪偵惉岟丂堦懱偳傫側傕偺丠撧椙導棫堛壢戝妛乿

2024擭7寧1擔

NHK撧椙
乽恖岺愒寣媴偺幚梡壔傪栚巜偡 撧椙導棫堛戝偱椪彴帋尡 奐巒傊乿

2024擭7寧1擔

婰幰夛尒丒僾儗僗儕儕乕僗偑偁傝傑偟偨丅
乽旛拁丒嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺惢憿偍傛傃丄戞堦憡椪彴帋尡傪撧椙導棫堛壢戝妛晬懏昦堾偱幚巤乿

TBS NEWS DIG

2024擭6寧5-7擔

戞73夞 崅暘巕擭師戝夛乮愬戜乯偵偰丄徏暯偑尋媶敪昞傪偟傑偟偨丅
墘戣丗巁慺暘埑偵墳摎偟偨擲抏惈傪帵偡僿儌僌儘價儞-PEG僎儖

2024擭5寧30擔

World Biomaterial Congress 2024 (戝绶)偵偰丄Keynote speaker偲偟偰島墘偟傑偟偨丅
墘戣丗Storable and ready-to-use artificial red cells (hemoglobin vesicles) as a resuscitative fluid for emergency medicine

2024擭5寧28擔

Langmuir帍偵丄恖岺愒寣媴惢嵻偺挿婜曐懚拞偵偍偗傞帀幙枌偺埨掕惈昡壙偵娭偡傞榑暥偑宖嵹偝傟傑偟偨丅
僞僀僩儖丗Stability of Liposomal Membrane of Hemoglobin-Vesicles (Artificial Red Cells) for Over Years of Storage Evaluated Using Liquid Chromatography-Mass Spectrometry
DOI:10.1021/acs.langmuir.4c01403

2024擭4寧23擔

Free Radical Biology and Medicine帍偵丄堦巁壔扽慺傪寢崌偟偨愒寣媴偺僒儖僐儁僯傾帯椕岠壥偑宖嵹偝傟傑偟偨(孎戝栻傎偐偲偺嫟摨尋媶)丅
DOI:10.1016/j.freeradbiomed.2024.04.231

2024擭4寧1擔

椷榓6擭搙壢妛尋媶旓曗彆嬥偺岎晅撪掕傪庴偗傑偟偨丅
徏暯悞丄婎斦尋媶(C)丄壽戣斣崋: 24K15750

2024擭3寧22擔

Biomedical Research帍偵丄恖岺愒寣媴偺攛愗彍弍拞偺弌寣惈僔儑僢僋偵懳偡傞慼惗岠壥偑宖嵹偝傟傑偟偨(嶉嬍堛戝丄搶奀戝偲偺嫟摨)丅
DOI:10.2220/biomedres.45.91

2024擭3寧18擔

椷榓5擭搙 擔杮堛椕尋媶奐敪婡峔(AMED) 嫶搉偟尋媶僾儘僌儔儉 僔乕僘俛乽旛拁丒嬞媫搳梌偑壜擻側恖岺愒寣媴惢嵻偺幚梡壔傪栚巜偡尋媶乿偺戞2夞斍夛媍傪丄WEB奐嵜偟傑偟偨丅

2024擭1寧25擔

戞35夞 崅暘巕僎儖尋媶摙榑夛乮搶嫗戝妛乯偵偰丄徏暯偑尋媶敪昞傪偟傑偟偨丅
墘戣丗 僿儌僌儘價儞偺僒僽儐僯僢僩娫憡屳嶌梡偵傛傝壦嫶偝傟偨挻暘巕億儕儅乕僎儖偺擲抏惈僗僀僢僠儞僌

2023擭埲慜怴拝忣曬